The FLASH Act streamlines how the federal government's Biomedical Advanced Research and Development Authority (BARDA) can acquire medical supplies, equipment, and services to respond to health emergencies. The bill expands BARDA's purchasing authority in three main ways: it allows follow-on production contracts to be awarded to companies without competitive bidding after they participate in initial prototype development; it permits the agency to purchase supplies for testing and experimentation using non-competitive procedures; and it enables acquisition of innovative commercial products and services through streamlined competitive processes. For large contracts exceeding $100 million, the bill requires the agency to document the product's effectiveness and notify Congress within 45 days, ensuring oversight while maintaining flexibility for rapid procurement during public health emergencies. Overall, the legislation aims to speed up the government's ability to develop and obtain critical medical countermeasures by reducing bureaucratic delays in emergency situations.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.